Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Robbert P. Van Manen"'
Autor:
Vera Battini, Robbert P. Van Manen, Michele Gringeri, Giulia Mosini, Greta Guarnieri, Anna Bombelli, Marco Pozzi, Maria Nobile, Sonia Radice, Emilio Clementi, Carla Carnovale
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Growing evidence supports a bidirectional association between diabetes and depression; promising but limited and conflicting data from human studies support the intriguing possibility that antidiabetic agents may be used to relieve effect
Externí odkaz:
https://doaj.org/article/66353f6e2011458e8a4a14c04d79d8e6
Autor:
Albaraa Mohammed N. Marran, Sonia Radice, Emilio Clementi, Vera Battini, Robbert P. van Manen, Faizan Mazhar, Marco Pozzi, Michele Gringeri, Giulia Mosini, Carla Carnovale, Shahzad Akram
Publikováno v:
Expert Opinion on Biological Therapy. 21:1281-1290
Background: Studies in patients with immune-mediated inflammatory diseases (IMIDs) have inconsistently suggested that anti-TNFα therapy may be associated with excessive weight gain. Research design and methods: We performed a nested case/non-case an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860afaf926137e3611d0f240fe5eaee2
https://doi.org/10.1080/14712598.2021.1948529
https://doi.org/10.1080/14712598.2021.1948529
Publikováno v:
Annals of Pharmacotherapy. 54:247-253
Background: Hypoglycemia is a rare adverse effect of tramadol that is described in the medical literature and package insert. Objective: The purpose of this study was to review reports of tramadol and hypoglycemia in the Food and Drug Administration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e292e59a2373ec45151016194bef4f
https://doi.org/10.1177/1060028019885643
https://doi.org/10.1177/1060028019885643
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(13)
Purpose The potential link between serious or life-threatening bleeding and the use of direct oral anticoagulants (DOACs) was evaluated. Methods Qualitative and quantitative reviews of case reports of bleeding events involving dabigatran, rivaroxaban
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1113343c6874a763849874e1bc35a8da
https://pubmed.ncbi.nlm.nih.gov/29735612
https://pubmed.ncbi.nlm.nih.gov/29735612
Autor:
Angela Nagel, Gabriela C. Cipriano, Nabila Ahmed-Sarwar, Jack Brown, Robbert P. van Manen, Paul M. Werner
Publikováno v:
Annals of Pharmacotherapy. 50:27-31
Background: To date, there is limited literature regarding the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and pancreatic carcinoma. Objective: To describe the comparative incidence of DPP-4 inhibitors and pancreatic carcinoma as re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d97a89a7933abd9b64967d0bc41fc7
https://doi.org/10.1177/1060028015610123
https://doi.org/10.1177/1060028015610123
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 33:63-68
tudy Objective To provide clinicians with an understanding of the comparative occurrence of tigecycline and pancreatitis, and to provide any clinically relevant characteristics that may be useful in identifying the patients at risk. Design Retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54eacee13888834bc0c7364a7d9f6b2
https://doi.org/10.1002/phar.1159
https://doi.org/10.1002/phar.1159
Publikováno v:
Pharmacotherapy. 31:585-590
Study Objective. To provide clinicians with an understanding of the comparative occurrence of linezolid and blindness, and to provide any clinically relevant characteristics that may be useful in identifying the patients at risk. Design. Retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb105d7d3aeb5c3c968edd7be08257f
https://doi.org/10.1592/phco.31.6.585
https://doi.org/10.1592/phco.31.6.585
Autor:
Mirza I. Rahman, Robbert P. van Manen
Publikováno v:
Principles and Practice of Pharmaceutical Medicine. :587-600
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2322ff7caba6dc87a3070a966bb79e29
https://doi.org/10.1002/9781444325263.ch44
https://doi.org/10.1002/9781444325263.ch44
Publikováno v:
Pharmacotherapy. 34(12)
Study Objective To review quantitatively and qualitatively the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database to provide clinicians with a general understanding of the comparative occurrence of clinically meani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065aa90bd183d2e95153afd14d71a63b
https://pubmed.ncbi.nlm.nih.gov/25421400
https://pubmed.ncbi.nlm.nih.gov/25421400
Autor:
Robbert P. van Manen
Publikováno v:
Drug Information Journal. 30:731-736
This paper presents an approach which allows companies to deal with some of the major problems associated with adverse event data management in both an effective and efficient way. It is based upon discussions with representatives of several pharmace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0319c866ca4f83ea0e606201ef63e17
https://doi.org/10.1177/009286159603000316
https://doi.org/10.1177/009286159603000316